Natixis’s COSCIENS Biopharma CSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-2,938
Closed -$220K – 1377
2021
Q3
$220K Buy
2,938
+707
+32% +$50.2K ﹤0.01% 1139
2021
Q2
$196K Buy
+2,231
New +$212K ﹤0.01% 819

Other funds holding CSCI

Natixis's CSCI Position: Q4 2021 in Review

Natixis sold out of COSCIENS Biopharma (CSCI) in Q4 2021, closing a stake of 2,938 shares — an estimated $220K sold.

Natixis first reported a position in CSCI in Q2 2021 and held it in 2 quarters. The position peaked at $220K in Q3 2021. 29 funds tracked by Wall St. Rank hold CSCI as of Q4 2021.

  • Natixis reported no remaining COSCIENS Biopharma position as of Q4 2021 after selling out during the quarter.
  • Natixis sold 2,938 COSCIENS Biopharma shares in Q4 2021, an estimated $220K.
  • Natixis first reported a position in COSCIENS Biopharma in Q2 2021 and held it in 2 quarters.
  • Natixis's COSCIENS Biopharma position peaked at $220K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held COSCIENS Biopharma as of Q4 2021.

Based on Natixis's 13F filing for Q4 2021, filed 14 Feb 2022.